Fresh analysis reveals that people who come off blockbuster weight-loss injections like semaglutide or tirzepatide may regain lost weight far faster than those who stop traditional lifestyle programs.
Research printed in a leading health publication points out that while obese individuals often shed a large proportion of their body weight while using the jabs, the weight is regained at an estimated rate of nearly a kilo each month once they quit.
"Users buying these treatments need to be cognizant of the risk of rapid weight regain when the medication is stopped," stated lead investigator Dr. Susan Jebb.
Such speed of regain suggests a return to original mass in about 18 months.
Weighing Therapies
The research, which looked at dozens of studies involving over 9,000 of patients, compared the effects of these new drugs with conventional dieting.
The team note that people who shed pounds through dieting usually see a more gradual creep back—approximately 100 grams monthly—after stopping.
Understanding the Quick Rebound
Experts believe the mode of action of the drugs accounts for the heightened rebound.
These medications copy a natural hormone called GLP-1, which controls feelings of fullness.
"Sustained high doses of the hormone concentrations far above than the body's typical production might result in the body to generate a reduced amount of its own natural GLP-1, and could diminish responsiveness to its effects," noted Dr. Adam Collins, a nutrition researcher.
"Stopping of this hormone supplement results in hunger is uncontrolled, making excessive eating much more probable."
A Lifelong Disease?
Medical guidelines suggest the jabs for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
Many experts argue that, due to the likelihood of weight regain, the therapy might need to be long-term.
This perspective is echoed by pharmaceutical companies, who state that the results "underscore the long-term character of excess weight," akin to managing conditions like hypertension.
User Accounts
Individuals who have stopped the medication report a powerful resurgence of hunger.
"I experienced a switch flipping and you become extremely hungry," described a patient.
This difficulty is exacerbated if individuals have not developed lasting lifestyle or habit modifications during therapy.
Significant Adoption
Survey data suggest that millions of people in the UK have used these injections in the past year, with demand being substantial.
- Adoption is higher among females compared to males.
- The middle-aged demographic shows the highest usage rates.
- A large proportion access the medications through private healthcare rather than the NHS.
Ultimately, experts stress that while these medications are effective agents for weight loss, they are not a standalone solution and maintained weight loss relies on ongoing behavioural changes.